Calculation of Dosimetry Parameters for 192Ir and 125I Brachytherapy Sources Using Geant4

被引:0
|
作者
Fonseca-Rodrigues, Sane S. O. [1 ]
Martins, Maximiano C. [1 ]
Begalli, Marcia [2 ]
Queiroz Filho, Pedro P. [1 ]
de Souza-Santos, Denison [1 ]
机构
[1] Inst Radioprotecao & Dosimetria, Rio de Janeiro, Brazil
[2] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil
关键词
D O I
暂无
中图分类号
TM [电工技术]; TN [电子技术、通信技术];
学科分类号
0808 ; 0809 ;
摘要
In brachytherapy cancer treatments, methods for calculation of dose delivered to tumours and organs have been continuously improving. Monte Carlo methods are na important tool in dose calculation for brachytherapy cancer treatments, where the exposition to the source planning aims at the maximization of dose deposition in the target volume, while minimizing the deposition in healthy tissues. The use of interstitial brachytherapy sources follows the recommendations of AAPM REPORT No.51. The present work is based on Monte Carlo simulations with the Geant4 toolkit of the dose quantities recommended by that report. An Iridium-192 Buchler HDR source and an Iodine-125 LDR source were simulated and the geometry of dose deposition in media and energy spectra have been obtained. Calculations also include the Dose Rate Constant Lambda, the Geometry Factor G(r, theta), the Anisotropy Function F(r, theta) and the Radial Dose Function g(r, theta).
引用
收藏
页码:1190 / 1192
页数:3
相关论文
共 50 条
  • [41] Positional and angular tracking of HDR 192Ir source for brachytherapy quality assurance using radiochromic film dosimetry
    Aldelaijan, Saad
    Devic, Slobodan
    Bekerat, Hamed
    Papaconstadopoulos, Pavlos
    Schneider, James
    Seuntjens, Jan
    Cormack, Robert A.
    Buzurovic, Ivan M.
    [J]. MEDICAL PHYSICS, 2020, 47 (12) : 6122 - 6139
  • [42] Head and neck 192Ir HDR-brachytherapy dosimetry using a grid-based Boltzmann solver
    Siebert, Frank-Andre
    Wolf, Sabine
    Kovacs, George
    [J]. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2013, 5 (04) : 232 - 235
  • [43] Comparison of radiation shielding requirements for HDR brachytherapy using 169Yb and 192Ir sources
    Lymperopoulou, G.
    Papagiannis, P.
    Sakelliou, L.
    Georgiou, E.
    Hourdakis, C. J.
    Baltas, D.
    [J]. MEDICAL PHYSICS, 2006, 33 (07) : 2541 - 2547
  • [44] Technical note:: Monte-Carlo dosimetry of the HDR 12i and plus 192Ir sources
    Ballester, F
    Puchades, V
    Lluch, JL
    Serrano-Andrés, MA
    Limami, Y
    Pérez-Calatayud, J
    Casal, E
    [J]. MEDICAL PHYSICS, 2001, 28 (12) : 2586 - 2591
  • [45] 不同人体组织中192Ir、125I粒子源的剂量分布研究
    汤晓斌
    陈飞达
    谢芹
    刘云鹏
    耿长冉
    陈达
    [J]. 中国医学物理学杂志, 2011, 28 (06) : 2971 - 2975
  • [46] Evaluation of dosimetric parameters for various 192ir brachytherapy sources under unbounded phantom geometry by Monte Carlo simulation
    Devan, Krishnamurthy
    Aruna, Prakasarao
    Manigandan, Durai
    Bharanidharan, Ganesan
    Subbaiah, Kamatam Venkata
    Sunny, Chiravath Sunil
    Ganesan, Singaravelu
    [J]. MEDICAL DOSIMETRY, 2007, 32 (04) : 305 - 315
  • [47] EVALUATION OF ELONGATED AND CURVED 192IR AND 103PD SOURCES USING A HYBRID TG-43 DOSIMETRY DOSE CALCULATION METHOD
    Bannon, E.
    Yang, Y.
    Rivard, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S405 - S406
  • [48] Design and Optimization of an HDR 192Ir Brachytherapy Applicator for Skin Irradiation Using Monte Carlo-based Dosimetry
    Yang, Y.
    Rivard, M. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S857 - S857
  • [49] Monte Carlo study of TG-43 dosimetry parameters of GammaMed Plus high dose rate 192Ir brachytherapy source using TOPAS
    Wu, Jianan
    Xie, Yaoqin
    Ding, Zhen
    Li, Feipeng
    Wang, Luhua
    [J]. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2021, 22 (06): : 146 - 153
  • [50] Mathematical formulation of 125I seed dosimetry parameters and heterogeneity correction in lung permanent implant brachytherapy
    Mostaghimi, Hesameddin
    Mehdizadeh, Ali Reza
    Darvish, Leili
    Akbari, Sadegh
    Rezaei, Hadi
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2017, 13 (03) : 436 - 441